日本の医薬品外観検査システム市場：2025年～2033年

日本の医薬品外観検査システム市場は、2024年に5,427万米ドルに達し、2033年には1,136億5,000万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは8.63%で成長すると予測されています。

製品の品質と安全性に対する要求の高まりは、日本における医薬品外観検査システムの重要な促進要因です。製薬業界はPMDAや厚生労働省などの規制機関からの監視の強化に直面しており、企業は厳しい基準への準拠を確実にするために高度な検査技術の導入を余儀なくされています。

これらのシステムは、医薬品の安全性と有効性を損なう可能性のある欠陥、汚染物質、または不整合を検出する上で極めて重要です。高品質な製造に対する日本の評価と消費者の信頼を維持する必要性から、製薬会社はAI、機械学習、その他の革新的技術を活用し、精度と効率を高める最先端の目視検査システムに投資しています。例えば、Daiichi Jitsugyo Viswillは2024年6月、デジタル化を取り入れ、世界リーダーと提携することで、イノベーションの限界に挑み続けると発表しました。このようなイノベーションへのコミットメントが、進化し続ける外観検査分野の卓越性に影響を与えています。

日本における医薬品外観検査システムに関連する高コストは、特に予算が限られている中小企業にとって、その導入や導入を大幅に抑制しています。これらのコストには、先進的な検査技術への初期投資だけでなく、システムの保守、校正、様々な機関によって設定された厳しい規制基準を満たすためのバリデーションに関連する継続的な費用も含まれます。

当レポートでは、日本の医薬品外観検査システム市場について調査し、市場の概要とともに、機械タイプ別、技術別、用途別、形態別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析

第5章 戦略的洞察と業界の展望

• 市場のリーダーと先駆者
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の調査
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• 特許分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格動向
• キーオピニオンリーダー

第6章 機会タイプ別

• 自動
• 半自動
• 手動

第7章 技術別

• ヘッドスペースガス分析（HGA）
• 高電圧リーク検出（HVLD）
• レーザー屈折
• その他

第8章 用途別

• 短期保管
• 長期保管

第9章 形態別

• タブレット
• カプセル
• ソフトジェル
• 注射器
• アンプル
• バイアル
• その他

第10章 競合情勢

第11章 企業プロファイル

• Keyence Corporation
• Ikegami Tsushinki Co., Ltd.
• Daiichi Jitsugyo Viswill Co., Ltd.
• Hitachi Industry &Control Solutions, Ltd.
• Stevanato Group SpA
• Maquinaria Industrial Dara, SL
• Qualicaps Co., Ltd.
• VITRONIC Machine Vision GmbH
• GFSpA
• ViSCO Technologies Corporation

第12章 付録

The Japan pharmaceutical visual inspection systems market reached US$ 54.27 million in 2024 and is expected to reach US$ 113.65 billion by 2033, growing at a CAGR of 8.63% during the forecast period 2025-2033.

Pharmaceutical Visual Inspection Systems are specialized technologies and equipment used in the pharmaceutical industry to inspect products for quality and safety. These systems are designed to detect defects, contamination, or irregularities in pharmaceutical products, including tablets, capsules, vials, ampoules, and syringes.

Market Dynamics: Drivers & Restraints

Growing Focus on Product Quality and Safety

The growing focus on product quality and safety requirements is a significant driver of pharmaceutical visual inspection systems in Japan. As the pharmaceutical industry faces increasing scrutiny from regulatory bodies such as the PMDA and the Ministry of Health, Labour, and Welfare, companies are compelled to adopt advanced inspection technologies to ensure compliance with stringent standards.

These systems are critical in detecting defects, contaminants, or inconsistencies that could compromise the safety and efficacy of pharmaceutical products. With Japan's reputation for high-quality manufacturing and the need to maintain consumer trust, pharmaceutical companies are investing in state-of-the-art visual inspection systems that utilize AI, machine learning, and other innovative technologies to enhance accuracy and efficiency. For instance, in June 2024, Daiichi Jitsugyo Viswill announced that it continues to push the boundaries of innovation by embracing digitalization and partnering with global leaders. This type of commitment to innovation and influences excellence in the ever-evolving field of visual inspection.

High cost associated with pharmaceutical visual inspection systems

The high cost associated with pharmaceutical visual inspection systems in Japan significantly restrains their adoption and implementation, particularly for smaller companies with limited budgets. These costs encompass not only the initial investment in advanced inspection technology but also the ongoing expenses related to system maintenance, calibration, and validation to meet stringent regulatory standards set by various agencies.

Segment Analysis

The Japan pharmaceutical visual inspection systems market is segmented based on machine type, technology, and application.

Product Type:

Automated inspection systems segment is expected to dominate the Japan pharmaceutical visual inspection systems market share

Automated inspection systems are a significant market player, focusing on efficiency and precision in quality control processes. They use robotics, machine learning, and high-resolution imaging to reduce human error and increase throughput. Analytical inspection, on the other hand, involves detailed analysis of pharmaceutical formulations using spectrometers and chromatographs. These inspections aim to enhance product reliability and regulatory compliance, driving innovation and adoption of advanced technologies in the Japanese pharmaceutical sector.

Automatic visual inspection systems (AVIS) are crucial in Japan's pharmaceutical industry for ensuring injectable product quality and safety. They use advanced technologies like machine vision and AI to automate inspection processes, ensuring regulatory compliance.

Japan's regulatory bodies mandate rigorous visual inspection of parenteral products to detect defects and foreign particulate matter (FPM), with 100% of containers required. AVIS systems, using high-resolution cameras and sophisticated image processing algorithms, can identify defects like cosmetic flaws, particulate contamination, and packaging defects. These systems can detect even minor anomalies that human inspectors might overlook, ensuring high product quality and patient safety.

Competitive Landscape

The major players in the Japan pharmaceutical visual inspection systems include Keyence Corporation, Ikegami Tsushinki Co., Ltd., Daiichi Jitsugyo Viswill Co., Ltd., Hitachi Industry & Control Solutions, Ltd., Stevanato Group SpA, Maquinaria Industrial Dara, S.L., Qualicaps Co., Ltd., VITRONIC Machine Vision GmbH, G.F. S.p.A. and ViSCO Technologies Corporation among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Pharmaceutical Visual Inspection Systems Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Machine Type
• 3.2. Snippet by Technology
• 3.3. Snippet by Application

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Growing Focus on Product Quality and Safety
  • 4.1.2. Restraints
    • 4.1.2.1. High cost associated with pharmaceutical visual inspection systems
  • 4.1.3. Opportunity
• 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

• 5.1. Market Leaders and Pioneers
  • 5.1.1. Emerging Pioneers and Prominent Players
  • 5.1.2. Established leaders with largest selling Brand
  • 5.1.3. Market leaders with established Product
• 5.2. CXO Perspectives
• 5.3. Latest Developments and Breakthroughs
• 5.4. Case Studies/Ongoing Research
• 5.5. Regulatory and Reimbursement Landscape
• 5.6. Porter's Five Force Analysis
• 5.7. Supply Chain Analysis
• 5.8. Patent Analysis
• 5.9. SWOT Analysis
• 5.10. Unmet Needs and Gaps
• 5.11. Recommended Strategies for Market Entry and Expansion
• 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 5.13. Pricing Analysis and Price Dynamics
• 5.14. Key Opinion Leaders

6. By Machine Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Machine Type
  • 6.1.2. Market Attractiveness Index, By Machine Type
• 6.2. Automatic*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Semi-Automatic
• 6.4. Manual

7. By Technology

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 7.1.2. Market Attractiveness Index, By Technology
• 7.2. Headspace Gas Analysis (HGA)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. High Voltage Leak Detection (HVLD)
• 7.4. Laser Refraction
• 7.5. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Short-Term Storage*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Long-Term Storage

9. By Technology

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 9.1.2. Market Attractiveness Index, By Technology
• 9.2. Tablets*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Capsules
• 9.4. Soft Gels
• 9.5. Syringes
• 9.6. Ampoules
• 9.7. Vials
• 9.8. Others

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

• 11.1. Keyence Corporation*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio
    • 11.1.2.1. Product Description
    • 11.1.2.2. Product Key Performance Indicators (KPIs)
    • 11.1.2.3. Historic and Forecasted Product Sales
    • 11.1.2.4. Product Sales Volume
  • 11.1.3. Financial Overview
    • 11.1.3.1. Company Revenue's
    • 11.1.3.2. Geographical Revenue Shares
    • 11.1.3.3. Revenue Forecasts
  • 11.1.4. Key Developments
    • 11.1.4.1. Mergers & Acquisitions
    • 11.1.4.2. Key Product Development Activities
    • 11.1.4.3. Regulatory Approvals etc.
  • 11.1.5. SWOT Analysis
• 11.2. Ikegami Tsushinki Co., Ltd.
• 11.3. Daiichi Jitsugyo Viswill Co., Ltd.
• 11.4. Hitachi Industry & Control Solutions, Ltd.
• 11.5. Stevanato Group SpA
• 11.6. Maquinaria Industrial Dara, S.L.
• 11.7. Qualicaps Co., Ltd.
• 11.8. VITRONIC Machine Vision GmbH
• 11.9. G.F. S.p.A.
• 11.10. ViSCO Technologies Corporation
• Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us